Fish oil is one of the most common supplements in American medicine cabinets, but the evidence for exactly what it does, and at what dose, has been scattered across dozens of small trials. A systematic review and meta-analysis published in November 2025 in Frontiers in Medicine pulled 41 randomized controlled trials together and looked at what happens to chronic pain when patients take omega-3 fatty acids over weeks and months.
Across 3,759 participants, the pooled effect was a moderate, statistically significant drop in pain intensity, with a standardized mean difference of -0.55. The authors translated that into roughly 11 to 14 millimeters on the familiar 0 to 100 pain scale, above the 10 mm threshold that clinicians treat as a meaningful improvement for a patient.
The dose finding many readers will not expect
The intuitive assumption with a supplement is that more is better. In this pooled analysis, that was not the case for pain. Trials that used a daily dose of 1.35 grams or less produced a slightly stronger effect (SMD -0.60) than trials using higher doses (SMD -0.53).
The authors describe the overall pattern as a "ceiling effect for dose escalation," meaning that pushing the daily dose higher did not translate into more pain relief in the data they had. That is a narrower and more sober conclusion than the marketing on many high-dose fish oil bottles would suggest.
Also read: Intermittent fasting may keep weight off for a full year, even after you stop the diet
Time mattered more than dose
Where the numbers moved in a clearer direction was with duration. After one month of supplementation the pooled effect was small (SMD -0.27). By three months it had grown to -0.51, and by six months it reached -0.83, a large effect by conventional statistical benchmarks.
In practical terms, this suggests omega-3 is not a fast-acting painkiller. Patients and clinicians looking for a change in symptoms should probably think in months, not days.
Which conditions actually improved
The pooled number hides a lot of variation. The clearest benefits showed up in inflammatory and neurovascular pain. Rheumatoid arthritis patients saw a moderate reduction (SMD -0.42), and the effect in migraine was large (SMD -0.84). A mixed chronic pain group also improved (SMD -0.61).
Osteoarthritis, which is driven more by joint wear than by systemic inflammation, did not show a statistically significant benefit in the analysis, and neither did mastalgia, a form of breast pain often tied to hormonal cycles. For patients whose pain is mechanical or hormonal rather than inflammatory, the evidence base here is weaker.
Also read: Daily cottage cheese: what a 2025 review says about muscle, blood sugar, and sodium
Context and cautions
Chronic pain is not a fringe problem in the United States. The CDC's National Center for Health Statistics reported in a November 2024 data brief that 24.3 percent of US adults had chronic pain in the past three months in 2023, and 8.5 percent had pain severe enough to frequently limit daily life or work. Women were more likely to be affected than men.
Against that backdrop, a supplement with a documented moderate effect is not trivial. The authors of the meta-analysis note that the size of the pain reduction they measured is broadly comparable to the effect seen with diclofenac, a common anti-inflammatory painkiller, while carrying a lower risk of the gastrointestinal and cardiovascular side effects associated with long-term NSAID use.
That comparison, however, comes from pooled averages across very different trials. The authors flag substantial heterogeneity between studies and possible publication bias, and they point out that concurrent painkiller use was not consistently reported in the underlying trials. Their conclusion is that omega-3 is a useful adjunct for chronic inflammatory pain, not a stand-alone replacement for prescribed treatment.
Before starting a supplement
The NIH Office of Dietary Supplements notes that high doses of omega-3 can increase the risk of bleeding, and that people taking warfarin or other anticoagulants should talk to a clinician before adding fish oil. Anyone dealing with chronic pain should raise a supplement plan with their own doctor rather than swap it in for prescribed medication, particularly if surgery is on the horizon or blood thinners are in the picture.
Also read: Scientists discover an unexpected benefit of creatine
Also read: AI found hidden sleep patterns that doubled death risk - and standard tests missed them